{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "8203649",
  "DateCompleted": {
    "Year": "1994",
    "Month": "07",
    "Day": "05"
  },
  "DateRevised": {
    "Year": "2017",
    "Month": "12",
    "Day": "13"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0002-9513",
      "JournalIssue": {
        "Volume": "266",
        "Issue": "5 Pt 2",
        "PubDate": {
          "Year": "1994",
          "Month": "May"
        }
      },
      "Title": "The American journal of physiology",
      "ISOAbbreviation": "Am J Physiol"
    },
    "ArticleTitle": "Interleukin-8 induces fever by a prostaglandin-independent mechanism.",
    "Pagination": {
      "StartPage": "R1670",
      "EndPage": "R1674",
      "MedlinePgn": "R1670-4"
    },
    "Abstract": {
      "AbstractText": [
        "We have studied the mechanism by which interleukin-8 (IL-8) induces fever in rats. Intracerebroventricular injections of IL-8 (5.5-50 ng) evoked dose-dependent increases in body temperature, which reached a plateau 5 h after injection, i.e., later than intracerebroventricular interleukin-1 beta (IL-1 beta; 2 h). The pyrogenic activity of IL-8 was not due to contamination with lipopolysaccharide (LPS) because preincubation of IL-8 with a specific antibody or boiling the IL-8 for 30 min abolished its activity but not that of LPS; also, IL-8 but not LPS induced fever in LPS-tolerant rats. Indomethacin significantly reduced the pyrogenic effects of intracerebroventricular injections of LPS and IL-1 beta but not responses to IL-8, suggesting that pyrogenic responses to IL-8 were mediated independently of prostaglandins. In contrast, dexamethasone markedly attenuated pyrogenic responses to IL-8 and IL-1 beta. These data suggest that inhibition of IL-8 by glucocorticoids contributes to the antipyretic effects of these drugs in fevers resistant to cyclooxygenase inhibitors."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Laboratory of Pharmacology, Faculty of Pharmaceutical Sciences, Universidade de S\u00e3o Paulo, Ribeir\u00e3o Preto, Brazil."
          }
        ],
        "LastName": "Zampronio",
        "ForeName": "A R",
        "Initials": "AR"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Souza",
        "ForeName": "G E",
        "Initials": "GE"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Silva",
        "ForeName": "C A",
        "Initials": "CA"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Cunha",
        "ForeName": "F Q",
        "Initials": "FQ"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Ferreira",
        "ForeName": "S H",
        "Initials": "SH"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Am J Physiol",
    "NlmUniqueID": "0370511",
    "ISSNLinking": "0002-9513"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Interleukin-8"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Lipopolysaccharides"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Prostaglandins"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Recombinant Proteins"
    },
    {
      "RegistryNumber": "7S5I7G3JQL",
      "NameOfSubstance": "Dexamethasone"
    },
    {
      "RegistryNumber": "XXE1CET956",
      "NameOfSubstance": "Indomethacin"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Body Temperature"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Body Temperature Regulation"
    },
    {
      "QualifierName": [
        "drug effects",
        "physiology"
      ],
      "DescriptorName": "Cerebral Ventricles"
    },
    {
      "QualifierName": [
        "pharmacology"
      ],
      "DescriptorName": "Dexamethasone"
    },
    {
      "QualifierName": [
        "chemically induced",
        "physiopathology"
      ],
      "DescriptorName": "Fever"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "pharmacology"
      ],
      "DescriptorName": "Indomethacin"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Injections, Intraventricular"
    },
    {
      "QualifierName": [
        "administration & dosage",
        "pharmacology"
      ],
      "DescriptorName": "Interleukin-8"
    },
    {
      "QualifierName": [
        "toxicity"
      ],
      "DescriptorName": "Lipopolysaccharides"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [
        "physiology"
      ],
      "DescriptorName": "Prostaglandins"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Rats"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Rats, Wistar"
    },
    {
      "QualifierName": [
        "administration & dosage",
        "pharmacology"
      ],
      "DescriptorName": "Recombinant Proteins"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Time Factors"
    }
  ]
}